Loading...
*  Long-term complications of liver transplantations - The Clinical Advisor
Due to drug-to-drug interaction with immunosuppression medications, NSAIDS, diabetes, or long-term calcineurin inhibitor use. ... Berenguer, M, Prieto, M, Rayon, J. "Natural history of clinically compensated HCV-related graft cirrhosis following liver ... Renal dysfunction. Calcineurin inhibitor (CNI) medications remain the principle cause of renal dysfunction. Initial therapy ... Renal dysfunction. Calcineurin inhibitors (cyclosporine/tacrolimus) and hepatorenal syndrome prior to transplantation are the ...
  https://www.clinicaladvisor.com/gastroenterology-hepatology/long-term-complications-of-liver-transplantations/article/596613/
*  Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation - Full...
mycophenolate mofetil and half their baseline dose of calcineurin inhibitor. Drug: mycophenolate mofetil mycophenolate mofetil ... diabetes mellitus, hyperlipidemia, and/or neurologic side effects. Stopping or reducing the dose of cyclosporine or tacrolimus ... Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation. This ... primary biliary cirrhosis. * Patients who have had:. *more than one prior episode of rejection, ...
  https://clinicaltrials.gov/ct2/show/NCT00206076
*  Autoimmune Hepatitis: A Review of Current Diagnosis and Treatment
... drug-induced disease, primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC). The alkaline phosphatase ... A combination of prednisone and a calcineurin inhibitor (tacrolimus more frequently than cyclosporine) is the most common ... However, unlike other cohorts of cirrhotic patients, the majority of patients with AIH respond well to immunosuppression and in ... Patients with brittle diabetes, severe osteoporosis, vertebral compression fractures, psychosis, obesity, and uncontrolled ...
  https://www.hindawi.com/journals/heprt/2011/390916/
*  Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant - Full Text View -...
Drug: calcineurin inhibitor-based immunosuppression Procedure: liver transplant Drug: corticosteroids Other: immunosuppression ... incomplete cirrhosis) and stage 6 is cirrhosis, probable or definite. ... However, these medications can cause long-term side effects, such as infection, kidney problems, diabetes, and cancer. In ... followed by maintenance doses of continuous calcineurin inhibitor-based immunosuppression therapy.. Drug: calcineurin inhibitor ...
  https://clinicaltrials.gov/show/NCT00135694
*  Medical Complications After Renal Transplantation
Calcineurin inhibitors, cyclosporine and tacrolimus may induce nephrotoxicity, neurotoxicity (especially tremor), diabetes, ... Drug toxicity Both calcineurin-inhibitors, cyclosporine and tacrolimus, produce nephrotoxicity. Acute elevation in serum ... It is closely linked to the degree of immunosuppression and thus to the frequency and intensity of rejection and its therapy. ... cirrhosis or carcinoma of liver. The patient as well as graft survival for HbsAg positive recipients are inferior when compared ...
  http://www.fmshk.com.hk/hkmd/jun2001/sf20010603.htm
*  TRANSPLANT MEDICINE: PART-1 Dental
Calcineurin inhibitor Neurotoxicity P-450 metabolized Nephrotoxicity Monitor CV systemPost-transplant diabetes mellitus May ... Primary biliary cirrhosis Biliary atresia (children) Chronic hepatitis Sclerosing cholangitis Pancreas Severe diabetes leading ... Significant drug interactions with allopurinol and ACE inhibitors AZA +CSA + corticosteroids as triple immunosuppressive ... Immunosuppression All allogeneic transplantations initially require immunosuppression if the transplanted organs are not to be ...
  http://www.rxpgonline.com/article1040.html
*  How we treat chronic graft-versus-host disease | Blood Journal
Premature closure of this trial at the end of phase 2 suggests that the expected benefit of omitting the calcineurin inhibitor ... disappearing when the intensity of immunosuppression is increased and reappearing when the intensity of immunosuppression is ... Other conditions such as eczema, iron overload, hypothyroidism, adrenal insufficiency, infections, or drug effect can be ... diabetes, hypertension, mood swings, cataract formation, and increased risk of infection. Many of these toxicities can be ...
  http://www.bloodjournal.org/content/125/4/606?sso-checked=true
*  US20020132763A1 - Deuterated cyclosporine analogs and their use as immunomodulating agents - Google Patents
Also disclosed are methods of producing the cyclosporine derivatives and method of producing immunosuppression with reduced ... CsA-CyP A complex inhibits the phosphatase activity of calcineurin and ultimately immunosuppression (Etzkorn, F. A., Chang, Z ... type 1 diabetes mellitus, inflammatory bowel disease, biliary cirrhosis, uveitis, multiple sclerosis and other disorders such ... The immunosuppressive drug, rapamycin, inhibits this pathway. [0007] * CsA is a potent inhibitor of TCR-mediated signal ...
  https://patents.google.com/patent/US20020132763A1/en
*  Steroid/drug-induced hyperglycemia - ONA
Visit us often for drug therapy testing results, patient care information and more. Download our FREE app today. ... A reduction in calcineurin inhibitor (CNI) dosage or a switch from tacrolimus to cyclosporine should also be considered. An ... Other risk factors for the development of drug-induced diabetes:. *. Obesity is a risk factor in drug-induced hyperglycemia and ... Uremia in renal failure can cause insulin resistance, and cirrhosis in hepatic failure can result in an abnormal OGGT in pre- ...
  https://www.oncologynurseadvisor.com/pediatrics/steroiddrug-induced-hyperglycemia/article/620156/
*  Application # 2017/0143726. ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS TO MODULATE T CELL RESPONSES - Patents.com
0186] Together with tacrolimus, cyclosporin is a calcineurin inhibitor. It has been in use since 1983 and is one of the most ... such as Type I diabetes), and drug addictions (such as nicotine addiction). Alternatively, the method can be used for pain ... and protein synthesis inhibitors. [0183] Cytotoxic antibiotics are also used for immunosuppression. Among these, dactinomycin ... 0231] Primary biliary cirrhosis, appears to be an autoimmune disease that affects the biliary epithelial cells (BECs) of the ...
  http://patents.com/us-20170143726.html
*  Post liver transplant - Hepatitis C - MedHelp
... cirrhosis and who were converted from calcineurin inhibitors to MMF monotherapy. RESULTS: The 36 men and 12 women, had a mean ... I was on the drug for a while and I wanted to stop but I cannot recall why. I think I was probably treating my HCV and since I ... The most common cause is diabetes mellitus. The second most common cause is long-standing, uncontrolled, hypertension. ... SRL-based immunosuppression was a safe alternative to CNI. Although early improvements were observed, withdrawing CNI and ...
  https://www.medhelp.org/posts/Hepatitis-C/Post-liver-transplant/show/689770
*  Autoimmune hepatitis - Renal and Urology News
Patients with inactive cirrhosis. Patients with "burned out" cirrhosis are at higher risk of drug-induced adverse events. ... an increase of the dose and an optimization of calcineurin inhibitor dose. In case of failure of this regimen, mycophenolate ... For instance, in obese patients, patients with osteoporosis, or patients with brittle diabetes, the steroid dose should be as ... Notably, it is challenging to detect the patients who do not require immunosuppression, and asymptomatic patients without ...
  https://www.renalandurologynews.com/gastroenterology-hepatology/autoimmune-hepatitis/article/596032/
*  Role of Direct Antiviral Agents in Treatment of Chronic Hepatitis C Infection in Renal Transplant Recipients
Immunosuppression. All of the forty-five patients were on triple drug immunosuppression. Thirty-nine patients (86.67%) were on ... Calcineurin inhibitor. DAA:. Direct antiviral agents. eGFR:. Estimated glomerular filtration rate. ESRD:. End stage renal ... Patients with Cirrhosis. There were five patients with compensated cirrhosis and all of them were old transplant patients. One ... M. Gürsoy, N. Güvener, R. Köksal et al., "Impact of HCV infection on development of posttransplantation diabetes mellitus in ...
  https://www.hindawi.com/journals/jtrans/2018/7579689/
*  Most recent papers with the keyword Antibiotic food | Read by QxMD
The immunosuppression regimen consisted of corticosteroids, calcineurin inhibitor, and mammalian target of rapamycin complex 1 ... and reduced drug accumulation by drug efflux pumps. Some of these mechanisms confer resistance to a specific class of ... present a case of a 61-year-old man with hepatocellular carcinoma and a previous history of metabolic and alcoholic cirrhosis ... diabetes OR diabetic Exclude a word using the 'minus' sign. Virchow -triad ...
  https://www.readbyqxmd.com/keyword/12093
*  Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant...
... onset of post-transplant diabetes mellitus (p=1.00) or urinary tract infection (p=0.60). The mean eGFR was similar in both ... Participants were randomized for conversion to EVR or maintenance of calcineurin inhibitors. Results: Thirty patients were ... Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review ... The antiproliferative drug (mycophenolic acid or azathioprine) was maintained and could not be permanently withdrawn during the ...
  http://bjn.org.br/details/2032/en-US/effect-of-conversion-from-calcineurin-inhibitors-to-everolimus-on-hepatitis-c-viremia-in-adult-kidney-transplant-recipients
*  Astagraf XL - FDA prescribing information, side effects and uses
Nephrotoxicity due to Astagraf XL and Drug Interactions. Astagraf XL, like other calcineurin-inhibitors, can cause acute or ... high blood sugar (diabetes). Your doctor may do certain tests to check for diabetes while you take Astagraf XL. Call your ... e "De novo" refers to immunosuppression starting at the time of transplantation; data from PK substudy of Study 2. f Tacrolimus ... Hepatobiliary Disorders: Hepatic failure, hepatic necrosis, cirrhosis, cholangitis, venoocclusive liver disease, bile duct ...
  https://www.drugs.com/pro/astagraf-xl.html
*  Childhood Hematopoietic Cell Transplantation (PDQ®): Treatment - Health Professional Information [NCI] - North Kansas City...
... a calcineurin inhibitor (e.g., cyclosporine or tacrolimus), a combination of a calcineurin inhibitor with methotrexate ( ... Genuth S, Alberti KG, Bennett P, et al.: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (11): 3160-7 ... Of note, higher rates of thyroid dysfunction occur with single-drug versus three-drug GVHD prophylaxis,[74] along with ... 12 mob(sooner if off immunosuppression). 14 mob(or 2 mo after first dose). 18 mob(or 6 mo after first dose). 24 mob. ...
  https://www.nkch.org/patients-visitors/health-library/healthwise-document-viewer/?id=ncicdr0000700000
*  Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of...
Several guidelines are available regarding the efficacy and safety of available drug treatments for inflammatory bowel diseases ... P. jiroveci prophylaxis is recommended when using ≥1 immunosuppressive drug (calcineurin inhibitor or TNFɑ antagonist) [104 258 ... The role of concomitant immunosuppression is controversial even if it seems to reduce drug reactions during infliximab infusion ... Methotrexate therapy is contraindicated in patients with active viral hepatitis, severe fibrosis or cirrhosis (stages F3 or F4 ...
  http://ibd-rc.com/safety-treatments-inflammatory-bowel-disease-clinical-practice-guidelines-italian-group-study/fulltext
*  Most recent papers in the shared collection Renal Transplantation | Read by QxMD
Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis. ... Personalized immunosuppression in elderly renal transplant recipients.. L E J Peeters, L M Andrews, D A Hesselink, B C M de ... Tacrolimus(Tac) is a first-line immunosuppressive drug used mainly after allogeneic organ transplant to reduce rejection. Tac ... for SLK transplantation were adopted in August 2017 and state SLK should be reserved for select patients with cirrhosis who ...
  https://www.readbyqxmd.com/shared-collection/1760
*  Astagraf XL (Tacrolimus Extended-release Capsules): Side Effects, Interactions, Warning, Dosage & Uses
... drug interactions, warnings, patient labeling, reviews, and related medications. ... Nephrotoxicity Due To ASTAGRAF XL And Drug Interactions. ASTAGRAF XL, like other calcineurin-inhibitors, can cause acute or ... high blood sugar (diabetes). Your doctor may do certain tests to check for diabetes while you take ASTAGRAF XL. Call your ... The risk appears to be related to the intensity and duration of immunosuppression rather than to the use of any specific agent ...
  https://www.rxlist.com/astagraf-xl-drug.htm
*  Hannah Valantine | Stanford Medicine Profiles
... hyperlipidemia and pre-existing diabetes) or to the side effects often associated with immunosuppression with calcineurin ... nephrotoxicity and new-onset diabetes after transplantation). The calcineurin inhibitors, cyclosporine and tacrolimus, ... The approach to immunosuppression currently practised by most centers is that of combination drug therapy, which allows low ... Recent data suggest that the prevalence of CAD in patients with cirrhosis is much greater than previously believed and likely ...
  https://med.stanford.edu/profiles/hannah-valantine
*  Free Nursing Flashcards about UTA NURS 4581 Exam 3
standard triple therapy for immunosuppression for transplants. usually includes a calcineurin inhibitor, a corticosteroid, and ... Cirrhosis drug therapy. no specific drug therapy for cirrhosis. However, a number of drugs are used to treat symptoms and ... HTN, diabetes, migraines, inflammatory conditions, sickle cell disease. transient ischemic attack (TIA). transient episode of ... Calcineurin inhibitors (e.g., tacrolimus and cyclosporine). Drugs used pre-treatment that bind with the CD3 antigen found on ...
  https://www.studystack.com/flashcard-2518529
*  Transplant Surgery - News & Events
Diabetes Center surgeons Peter Stock, (left) and Chris Freise (right) have been pioneering new methods of immunosuppression for ... showed better organ survival in kidney transplant recipients than a calcineurin inhibitor, the current standard of care. The ... Researchers Convert Cirrhosis-Causing Cells to Healthy Liver Cells in Mice. Willenbring Lab - by Richard Barg - June 03, 2016 ... Before drug cocktails turned HIV from a death sentence to a chronic condition, patients were not eligible to receive a kidney. ...
  https://transplant.surgery.ucsf.edu/news--events.aspx?start=0&show=all
*  Lichen Planus - The Clinical Advisor
Topical calcineurin inhibitor (tacrolimus 0.03% or 0.1% ointment). Must counsel patients not to overapply. CO2 laser ablation. ... Limited by drug-induced hair loss and mucocutaneous side effects. Pioglitazone 15mg orally daily for 6 to 8 months; 1 case ... Patients with diabetes and OLP have a higher rate of erosive OLP. Patients with LP do not have a higher risk of developing ... LP has also been associated with HBV immunization and primary biliary cirrhosis. Routine screeing for HLA-DR6 is not done. ...
  https://www.clinicaladvisor.com/dermatology/lichen-planus/article/589089/
*  Autoimmune hepatitis
Patients with inactive cirrhosis. Patients with "burned out" cirrhosis are at higher risk of drug-induced adverse events. ... an increase of the dose and an optimization of calcineurin inhibitor dose. In case of failure of this regimen, mycophenolate ... Higher Reoperation Rates After Microvascular Decompression in Patients With Diabetes, Obesity * Updated Criteria for CRPS ... Notably, it is challenging to detect the patients who do not require immunosuppression, and asymptomatic patients without ...
  http://www.clinicalpainadvisor.com/gastroenterology-hepatology/autoimmune-hepatitis/article/596037/